Showing 341-350 of 2148 results for "".
AAD Treatment Evolution: The Future of Emerging Therapies
https://practicalneurology.com/programs/cme/aad-treatment-evolution-the-future-of-emerging-therapies/27103/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Burden Beyond the Patient: AAD's Impact on Patients and Caregivers
https://practicalneurology.com/programs/cme/burden-beyond-the-patient-aads-impact-on-patients-and-caregivers/27094/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Movement Disorders Moment: Neuropsychiatric Symptoms in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-neuropsychiatric-symptoms-in-parkinson-disease/31880/Broader awareness and assessment of neuropsychiatric symptoms are needed.Early Warning: Clinical Signs of AAD Every PCP and Caregiver Should Know
https://practicalneurology.com/programs/cme/early-warning-clinical-signs-of-aad-every-pcp-and-caregiver-should-know/27095/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Proactive Screening: Essential Tools for Diagnosing AAD Quickly
https://practicalneurology.com/programs/cme/proactive-screening-essential-tools-for-diagnosing-aad-quickly/27096/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Cerebral Vasoconstriction and Vasospastic Angina Secondary to Pheochromocytoma
https://practicalneurology.com/diseases-diagnoses/headache-pain/cerebral-vasoconstriction-and-vasospastic-angina-secondary-to-pheochromocytoma/31979/This is the first reported case of pheochromocytoma associated with both RCVS and vasospastic angina in the same patient.Caregiver Screening Tools for Agitation in Alzheimer’s Disease
https://practicalneurology.com/programs/cme/caregiver-screening-tools-for-agitation-in-alzheimers-disease/28795/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Safety, Efficacy, and Black Box Warnings: Challenges Associated With Off-Label Treatments of AAD
https://practicalneurology.com/programs/cme/safety-efficacy-and-black-box-warnings-challenges-associated-with-off-label-treatments-of-aad/27099/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Team Approach: Enhancing Collaboration in AAD Management
https://practicalneurology.com/programs/cme/team-approach-enhancing-collaboration-in-aad-management/27097/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Selection and Interpretation of Biomarker Tests for Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/selection-and-interpretation-of-biomarker-tests-for-alzheimer-disease/36191/Diagnostic tests for Alzheimer disease can help guide clinical management, but results must be interpreted carefully.